Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 32668 total
MSTR clawed back 12% on the week to close at $97.36 — a partial recovery from last week's collapse to $86.93 — but Tuesday's 3.4% single-day slide is a reminder that the bounce has not resolved the fundamental tension…
Microsoft heads into the final three weeks before its July 30 earnings date with the options defensiveness that dominated June now meaningfully unwound — and a borrow market that has done a sharp U-turn from the note…
MRCY enters the week on the back foot — a sharp 5.9% single-day decline on Tuesday cut the stock to $115.83, even as its defense-tech peers absorbed the session with far smaller losses, sharpening the question of…
Merck & Co. is consolidating around the Street consensus after a strong month, with Wells Fargo lifting its target today and options traders remaining more bullish than their recent habit. The most active data point…
S&P Global enters its Q2 earnings window with a notable divergence: the stock just posted its best weekly gain in months, yet every major Wall Street firm covering it cut its price target within the past 48 hours. The…
MasTec enters the second week of July nursing a sharp 14% decline, yet its analyst community is actually raising price targets — a rare divergence between price action and Street conviction that makes this week's setup…
Martin Marietta Materials heads into its July 30 earnings report with analyst sentiment quietly firming, even as the stock trades well below where most of the Street has it priced. The most immediate story is on the…
Marsh & McLennan heads into its July 16 Q1 results with the stock up sharply but analysts diverging on whether the move has gone too far. The price action this week is the first thing to address. The stock gained…
Lockheed Martin has added another 5% in the past week to close at $535.38 — but options traders are the most defensively positioned they've been in almost a year, and Q2 earnings arrive on July 21. The options market…
Eli Lilly and Company enters the back half of the week at $1,235.56, up 3% on the week, with a chorus of freshly raised analyst targets and an August 5 earnings date pulling focus. The Street's conviction is running…
LGND heads into the week at $319.43 with a striking split: the Street just raised its price target to a 52-week high while short sellers have quietly doubled their position over the past month. The tension between…
LEN heads into the second half of 2026 with the stock down 4% on the week, a consensus sell rating from the Street, and options traders adding defensive cover at the fastest pace in months. The options picture is the…
LTC Properties heads into its August 5 earnings report on a quiet but constructive note — the stock is up, shorts are modest, borrow is cheap, and two insiders bought the stock at lower prices just weeks ago. The…
Kirby Corporation heads into its Q2 report with the Street's most influential voice turning more constructive, even as the stock has pulled back from recent highs. BofA Securities analyst Ken Hoexter raised his price…
KMB enters its July 21 earnings report with an unusual combination: a 15% rally over the past month, short interest near a multi-month high, and a Street that is quietly growing more constructive even as bears circle…
Johnson & Johnson has moved further ahead of consensus this week, with the stock now trading above even the most recently upgraded analyst targets and Q2 earnings just six days away. The Street played catch-up on…
Jacobs Solutions heads into its August 4 earnings date with the stock up 6% over the past month and options traders unusually bullish — a setup that contrasts with a modest short position that has barely moved. The…
JPMorgan Chase enters its Q2 earnings week — results drop July 14 — having added 3.6% in the past five trading sessions to close at $339.22, with analysts racing to keep pace by lifting price targets ahead of the…
Intel has done something this week it hasn't managed in months: the stock has fallen back below the analyst consensus mean, ending Tuesday at $110.39 after a 21% weekly decline from the June 30 peak of $139.63. That is…
IART heads into its August 4 earnings print with a notable divergence: short sellers have been quietly retreating for six weeks straight, yet the CFO just sold shares near the top of the recent range. The most…
